[MYX] QoQ Quarter Result on 31-Dec-2022 [#Q2]

Stock
[MYX] Mayne Pharma Group Limited
Announcement Date
30-Dec-2022
Financial Year
2023
Quarter
31-Dec-2022 [#Q2]
Profit Trend
QoQ- 32.12%
YoY- -187.03%
Quarter Report
MYX's Result
MYX's Financial Summary
View:
Show?
Quarter Result
30/06/24 31/12/23 30/06/23 31/12/22 30/06/22 31/12/21 30/06/21 CAGR
Revenue 200,473 187,926 82,421 101,165 228,362 196,435 191,939 1.45%
PBT -115,222 -74,865 -103,161 -166,537 -154,116 -63,702 -34,632 49.23%
Tax -17,152 -4,316 85,107 -37,362 69,237 -13,105 -7,229 33.34%
NP -103,681 -70,552 -171,844 -144,575 -212,973 -50,370 -27,137 56.26%
Tax Rate - - - - - - - -
Total Cost 304,154 258,478 254,265 245,740 441,335 246,805 219,076 11.54%
Ratio Analysis
30/06/24 31/12/23 30/06/23 31/12/22 30/06/22 31/12/21 30/06/21 CAGR
NP Margin -51.72 -37.54 -208.50 -142.91 -93.26 -25.64 -14.14 54.01%
Per Share
30/06/24 31/12/23 30/06/23 31/12/22 30/06/22 31/12/21 30/06/21 CAGR
EPS -1.28 -0.87 -2.06 -1.64 -2.41 -0.62 -0.31 60.35%
EPS Diluted -1.31 -0.87 -2.06 -1.64 -2.41 -0.62 -0.31 61.60%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.